Specific microRNA Profile Associated with Inflammation and Lipid Metabolism for Stratifying Allergic Asthma Severity

Andrea Escolar-Peña,María Isabel Delgado-Dolset,Carmela Pablo-Torres,Carlos Tarin,Leticia Mera-Berriatua,María del Pilar Cuesta Apausa,Heleia González Cuervo,Rinku Sharma,Alvin T. Kho,Kelan G. Tantisira,Michael J. McGeachie,Rocio Rebollido-Rios,Domingo Barber,Teresa Carrillo,Elena Izquierdo,María M. Escribese
DOI: https://doi.org/10.3390/ijms25179425
IF: 5.6
2024-09-02
International Journal of Molecular Sciences
Abstract:The mechanisms underlying severe allergic asthma are complex and unknown, meaning it is a challenge to provide the most appropriate treatment. This study aimed to identify novel biomarkers for stratifying allergic asthmatic patients according to severity, and to uncover the biological mechanisms that lead to the development of the severe uncontrolled phenotype. By using miRNA PCR panels, we analyzed the expression of 752 miRNAs in serum samples from control subjects (n = 15) and mild (n = 11) and severe uncontrolled (n = 10) allergic asthmatic patients. We identified 40 differentially expressed miRNAs between severe uncontrolled and mild allergic asthmatic patients. Functional enrichment analysis revealed signatures related to inflammation, angiogenesis, lipid metabolism and mRNA regulation. A random forest classifier trained with DE miRNAs achieved a high accuracy of 97% for severe uncontrolled patient stratification. Validation of the identified biomarkers was performed on a subset of allergic asthmatic patients from the CAMP cohort at Brigham and Women's Hospital, Harvard Medical School. Four of these miRNAs (hsa-miR-99b-5p, hsa-miR-451a, hsa-miR-326 and hsa-miR-505-3p) were validated, pointing towards their potential as biomarkers for stratifying allergic asthmatic patients by severity and providing insights into severe uncontrolled asthma molecular pathways.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?